期刊文献+

人肺腺癌紫杉醇耐药细胞株的建立及其生物学特性研究 被引量:8

Establishment and characteristics of a paclitaxel resistant human lung adenocarcinoma cell subline(SPC-A1/Taxol)
下载PDF
导出
摘要 目的建立耐紫杉醇的人肺腺癌细胞株模型SPC-A1/Taxol,并初步研究其生物学特性。方法应用浓度递增和短时作用法,从人肺腺癌细胞株SPC-A1中诱导分离出对紫杉醇耐药的细胞亚株(SPC-A1/Taxol)。采用MTT法检测耐药细胞的耐药指数及对抗癌药物的敏感性;光镜和透射电镜观察细胞形态;以流式细胞术检测该耐药细胞的细胞周期分布;以免疫细胞化学染色检测多药耐药基因(mdr1)的表达产物P-糖蛋白(P-gp)。结果经MTT法检测,SPC-A1/Taxol细胞的紫杉醇半数抑制浓度(IC50)是亲代SPC-A1细胞的759.46倍,对Taxotere、NVB、ADM呈高度耐药状态,对VP-16和HCPT有轻度的耐药,而对DDP、GEM以及中药榄香烯乳无交叉耐药现象。耐药细胞的群体倍增时间是亲代细胞的1.32倍;细胞形态未见明显改变;G0+G1细胞比例减少,S期细胞增多。SPC-A1细胞无P-gp表达,SPC-A1/Taxol则高表达P-gp。结论SPC-A1/Taxol肺腺癌细胞株是一个明确的多药耐药模型,具有耐药细胞的基本生物学特性,推测其多药耐药性与P-gp的高表达相关。 Objective:To establish a new paclitaxel resistant human lung adenocarcinoma cell subline (SPC-A1/Taxol) and investigate its characteristics. Methods: A paclitaxel resistant human lung adenocarcinoma cell subline(SPC-A1/Taxol) was developed by intermittent exposure to gradually increasing concentration of Taxol from the parent cell line SPC-A1 in vitro. The multidrug resistance of SPC-A1/Taxol to anticancer agents was evaluated by MTT assay. The morphological features and the celluar ultrastructure characteristics were observed respectively by light microscopy and transmission electron microscopy. The distribution of its cell cycle was detected by flow cytometry. The expression of P-glycoprotein (P-gp) was detected by immunocytochemistry staining. Results:SPC-A1/ Taxol cells were of 759. 46-fold resistance to Taxol and displayed high resistance to Taxotere, NVB, ADM, but low resistance with VP-16and HCPT. No cross-resistance was observed to DDP,GEM and Elemene emusion. Comparing with the parent cells, the multiplication time of SPC-A1/Taxol cells was prolonged, their morphology was not changed obviously, and the proportion of cells in (G0 + G1 )-phase decreased while those in S-phase increased. The expression of P-gp in resistant cells was significantly higher than in their parent cells. Conclusions:SPC-A1/Taxol cell subline is a typical multidrug-resistant cell line which has basic characteristics of drugresistance cells. It was supposed that the multidrug resistance of SPC-A1/Taxol was related to the over expression of P-gp.
出处 《临床肿瘤学杂志》 CAS 2006年第9期657-661,共5页 Chinese Clinical Oncology
关键词 肺腺癌细胞 多药耐药 紫杉醇 细胞株 Human lung adenocarcinoma cell Multidrug resistance Paclitaxel Cell line
  • 相关文献

参考文献8

二级参考文献19

  • 1李羲,郭先健,张楚毅,钱桂生,李淑平.人肺腺癌多药抗药性细胞系LC─3/CDDP的建立及其特征观察[J].肿瘤,1995,15(6):488-490. 被引量:2
  • 2Chu J J, Chiang CD, Rao CS, et al. Establishment and charactcerization of a paclitaxel-resistant human non-- small cell lung cancer cell line[J]. Anticancer Res,2000,20(4) :2 449--2 456.
  • 3Yang L Y,Cancer Res,1990年,50卷,3218页
  • 4Schondoff T,Kurbacher C,Gohring U,et al.Induction of MDR1-gene expression by antineolastic agents in ovarian cancer cell lines[J].Anticancer Res,2002,22(4):2199-2203.
  • 5Di Nicolantonio F,Knight LA,Whitehouse PA,et al.The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samples[J].Mol Cancer Ther,2004,3(12):1631-1637.
  • 6Lister-Sharp D,McDonagh MS,Khan KS,et al.A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer[J].Health Technol Assess,2000,4(17):53-79.
  • 7Kamazawa S,Kigawa J,Kanamori Y,et al.Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer[J].Gynecol Oncol,2002,86(2):171-176.
  • 8Yamamoto K,Kikuchi Y,Kudoh K,et al.Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines[J].J Cancer Res Clin Oncol,2000,126(3):168-172.
  • 9Li L,Luan Y,Wang G,et al.Development and characterization of five cell models for chemoresistance studies of human ovarian carcinoma[J].Int J Mol Med,2004,14(2):257 -264.
  • 10Parekh H,Wiesen K,Simpkins H.Acquisition of taxol resistance via P-glycoprotein-and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells[J].Biochem Pharmacol,1997,53(4):461-470.

共引文献53

同被引文献137

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部